Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation in Bruxism
Launched by BANDIRMA ONYEDI EYLÜL UNIVERSITY · Apr 24, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called transcutaneous auricular vagus nerve stimulation (TAVNS) to see how well it helps people with bruxism, which is the habit of grinding or clenching teeth. The researchers want to learn if TAVNS can reduce muscle activity in the jaw, decrease pain, lower stress levels, improve sleep and overall quality of life, and positively affect the body's automatic functions.
To participate in this study, individuals must be between 18 and 65 years old and have been diagnosed with bruxism for at least six months. They should also experience pain in their jaw muscles. However, some people won't be eligible, such as those who have recently received Botox injections in the jaw, those who take certain pain medications, or those with specific health conditions affecting the jaw or neck. Participants can expect to undergo TAVNS treatment and may be monitored for improvements in their symptoms. This trial is not yet recruiting participants, so there will be more information available soon for those interested.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with bruxism between the ages of 18-65,
- • A history of bruxism for at least 6 months,
- • Individuals with masseter muscle pain GAS≥4 at rest and during mastication
- Exclusion Criteria:
- • Masseter botox application in the last 6 months,
- • Regular use of analgesics and anti-inflammatories that affect the OSS,
- • Presence of infection or tumoral structures within intraoral structures,
- • Wearing multiple ear piercings,
- • With TMJ disc displacement and joint degeneration,
- • Musculoskeletal problem with evidence of cervical or TMJ fracture, systemic disease, specific pathologic condition,
- • Any surgical operation related to a cervical or TMJ problem,
- • Less than 6 months of cervical or TMJ-related physiotherapy and rehabilitation services,
- • The one with facial paralysis,
- • Diagnosed psychiatric illness
About Bandırma Onyedi Eylül University
Bandırma Onyedi Eylül University is a reputable academic institution committed to advancing medical research and innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate high-quality research initiatives aimed at improving healthcare outcomes. With a focus on collaboration and ethical standards, Bandırma Onyedi Eylül University actively engages in studies that explore novel treatments and interventions, contributing to the body of scientific knowledge while prioritizing patient safety and well-being. Through its dedication to rigorous research methodologies and multidisciplinary approaches, the university plays a vital role in the development of evidence-based practices in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Balıkesir, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported